Reliable POCT Solutions for Rapid Diagnostics

OEM & CMO/CDMO
25 years of expertise

Dual Lateral Flow Platform

We offer both gold-conjugated and fluorescence immunoassay technologies, enabling flexible POCT deployment across a wide range of clinical settings, from basic healthcare clinics to advanced diagnostic centers.

Scalable OEM Manufacturing

We provide full OEM/CDMO capability with validated production lines, ISO 13485 compliance, and multi-format assembly (cassette, strip, reagents), enabling partners to launch branded POCT products quickly.

Validated Multi-Marker Portfolio

We develop broad diagnostic panels (cardiac, infection, inflammation, hormones, tumor markers) with strong clinical validation, ensuring relevance across emergency, chronic, and infectious disease testing.

Diagnostic Solutions

Welcome to KSB

Shenzhen Kangshengbao Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research, development, manufacturing, and commercialization of in vitro diagnostic (IVD) products. With a strong foundation in advanced diagnostic technologies and a robust quality management system, the company is committed to delivering reliable, high-performance products to global markets. Guided by a customer-centric approach, we strive to maintain the highest standards in quality, regulatory compliance, and service excellence.

Clinical Biomarkers

Marker Series enables multiplex biomarker detection for clinical diagnostics, delivering high sensitivity, broad analyte coverage, and reliable performance across point-of-care testing environments.

Quantitative Gold-Conjugated Assay

Colloidal Gold Quantitative Test provides precise concentration measurement of target analytes using rapid immunochromatographic technology with digital or reader-based signal quantification.

Qualitative Gold-Conjugated Assay

Colloidal Gold Qualitative Test delivers fast yes-or-no diagnostic results for infectious and clinical markers using simple, robust lateral flow immunoassay formats.

Fluorescence Assay

Fluorescence Assay platform offers ultra-sensitive detection of low-abundance biomarkers, enabling accurate quantitative analysis through advanced fluorescence signal amplification and reader integration.

Proven Diagnostics, Ready for Your Brand​​​

Products with CE Mark
0 +
Years of IVD Expertise
0
Products sold to Europe
0 %
Successful Tech Transfers
0 +

Let’s advance point-of-care diagnostics together

We develop and manufacture lateral flow immunoassays and POCT solutions for partners across diagnostics, life sciences, and healthcare. From custom assay development to OEM manufacturing, we support the full product lifecycle.